Relation between soy-associated isoflavones and LDL and HDL cholesterol concentrations in humans: A meta-analysis

European Journal of Clinical Nutrition

Volumn 57, Issue 8, 2003, Pages 940-946

  Weggemans, R M ^a   Trautwein, Elke A ^a  

^a UNILEVER RESEARCH VLAARDINGEN   (Netherlands)

Author keywords

Cholesterol; HDL; Isoflavones; Isoflavonoids; LDL; Soy protein

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; ISOFLAVONE DERIVATIVE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; SOYBEAN PROTEIN;

ADULT; AGED; ANIMAL PRODUCT; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION COEFFICIENT; DAIRY PRODUCT; FEMALE; HUMAN; MALE; MEDLINE; META ANALYSIS; NUTRITIONAL REQUIREMENT; NUTRITIONAL VALUE; PROTEIN INTAKE; REVIEW;

ADULT; AGED; CHOLESTEROL, HDL; CHOLESTEROL, LDL; DIETARY PROTEINS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; HYPERCHOLESTEROLEMIA; ISOFLAVONES; MALE; MEDLINE; MIDDLE AGED; SOYBEAN PROTEINS;

ANIMALIA; GLYCINE MAX;

EID: 0043025572     PISSN: 09543007     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.ejcn.1601628     Document Type: Review

References (34)

1. Anderson JW, Johnstone BM & Cook-Newell ME (1995): Meta-analysis of the effects of soy protein intake on serum lipids. N. Engl. J. Med. 333, 276-282.
2. Anthony MS, Blair RM & Clarkson TB (2002): Neither isoflavones nor the alcohol-extracted fraction added to alcohol-washed soy protein isolate restores the lipoprotein effects of soy protein isolate [abstract]. J. Nutr. 132, 583S.
3. Ashton E & Ball M (2000): Effects of soy as tofu vs meat on lipoprotein concentrations. Eur. J. Clin. Nutr. 54, 14-19.
4. Axelson M, Sjovall J, Gustafsson BE & Setchell KD (1984): Soya - a dietary source of the non-steroidal oestrogen equol in man and animals. J. Endocrinol. 102, 49-56.
5. Baum JA, Teng H, Erdman JW, Weigel RM, Klein BF, Persky VW, Freels S, Surya, P, Bakhit RM, Ramos E, Shay NF & Potter SM (1998): Long-term intake of soy protein improves blood lipid profiles and increases mononuclear cell low-density-lipoprotein receptor messenger RNA in hypercholesterolemic, postmenopausal women. Am. J. Clin. Nutr. 68, 545-551.
6. Boden WE (2000): High-density lipoprotein cholesterol as an independent risk factor in cardiovascular disease: assessing the data from Framingham to the Veterans Affairs High-Density Lipoprotein Intervention Trial. Am. J. Cardiol. 86, 19L-22L.
7. Crouse JR, Morgan T, Terry JG, Ellis J, Vitolins M & Burke GL (1999): A randomized trial comparing the effect of casein with that of soy protein containing varying amounts of isoflavones on plasma concentrations of lipids and lipoproteins. Arch. Intern. Med. 159, 2070-2076.
8. Dent SB, Peterson CT, Brace LD, Swain JH, Reddy MB, Hanson KB, Robinson JG & Alekel DL. (2001): Soy protein intake by perimenopausal women does not affect circulating lipids and lipoproteins or coagulation and fibrinolytic factors. J. Nutr. 131, 2280-2287.
9. Dewell A, Hollenbeck CB & Bruce B (2002): The effects of soy-derived phytoestrogens on serum lipids and lipoproteins in moderately hypercholesterolemic postmenopausal women. J. Clin. Endocrinol. Metab. 87, 118-121.
10. Egger M, Davey SG, Schneider M & Minder C (1997): Bias in meta-analysis detected by a simple, graphical test. Br. Med. J. 315, 629-634.
11. Erdman JW (2000): Soy protein and cardiovascular disease. A statement for healthcare professionals form the nutrition committee of the AHA. Circulation 102, 2555-2559.
12. Expert Panel on Detection Evaluation and Treatment of High Blood Cholesterol in Adults (2001): National Cholesterol Education Program (NCEP) Adult Treatment Panel III Report. http://www.nhlbi.nih.gov/guidelines/cholesterol/atp3_rpt.htm (10 December 2001).
13. Gardner CD, Newell KA, Cherin R & Haskell WL (2001): The effect of soy protein with or without isoflavones relative to milk protein on plasma lipids in hypercholesterolemic postmenopausal women. Am. J. Clin. Nutr. 73, 728-735.
14. Jenkins DJA, Kendall CWC, Jackson CJ, Connelly PW, Parker T, Faulkner D, Vidgen E, Cunnane SC, Leiter LA & Josse RG (2002): Effects of high and low isoflavone soy foods on blood lipids, oxidized LDL, homocysteine and blood pressure in hyperlipemic men and women. Am. J. Clin. Nutr. 76, 365-372
15. Kleinbaum DG, Kupper LL & Morgenstern H. (1988): Applied Regression Analysis and Other Multivariable Methods. 2nd edition. Belmont, Duxbury Press.
16. Laboratory Methods Committee of the Lipids Research Clinics Program (1977): Cholesterol and triglyceride concentrations in serum/plasma pairs. Clin. Chem. 23, 60-63.
17. Law M (2000): Plant sterol and stanol margarines and health. Br. Med. J. 320, 861-864.
18. Law MR, Wald NJ & Thompson SG (1994): By how much and how quickly does reduction in serum cholesterol concentration lower risk of ischaemic heart disease? Brit. Med. J. 308, 367-372.
19. Lichtenstein AH. (2001): Got soy? Am. J. Clin. Nutr. 73, 667-668.
20. Meinertz H, Nilausen K & Hilden J (2002): Alcohol-extracted, but not intact, dietary soy protein lowers lipoprotein(a) markedly. Arterioscler. Thromb. Vasc. Biol. 22, 312-316.
21. Meyer BJ, Larkin TA, Owen AJ, Astheimer LB, Tapsell L & Howe PRC (2002): The hypocholesterolaemic effect of chronic soy supplementation may be linked to equol. (abstract) In: Proceedings of conference Soy & Health 2002. Clinical evidence - dietetic applications. May 30-31, 2002, London, UK.
22. Morito K, Hirose T, Kinjo J, Hirakawa T, Okawa M, Nohara T, Ogawa S, Inoue S, Muramatsu M & Masamune Y (2001): Interaction of phytoestrogens with estrogen receptors alpha and beta. Biol. Pharm. Bull. 24, 351-356.
23. Oakenfull DG (2001): Soy protein, saponins and plasma cholesterol. J. Nutr. 131, 2971.
24. Potter SM (1995): Overview of proposed mechanisms for the hypocholesterolemic effect of soy. J. Nutr. 125, 606S-611S.
25. Samman S, Lyons WPM, Chan GS, Smith SJ & Petocz P (1999): The effect of supplementation with isoflavones on plasma lipids and oxidisability of low density lipoprotein in premenopausal women. Atherosclerosis 147, 277-283.
26. Setchell KD, Borriello SP, Hulme F, Kirk DN & Axelson M (1984): Nonsteroidal estrogens of dietary origin: possible roles in hormone-dependent disease. Am. J. Clin. Nutr. 40, 569-578.
27. Simons LA, von Konigsmark M, Simons J & Celermajer DS (2000): Phytoestrogens do not influence lipoprotein levels or endothelial function in healthy, postmenopausal women. Am. J. Cardiol. 85, 1297-1301.
28. Sirtori CR & Lovati MR (2001): Soy proteins and cardiovascular disease. Curr. Atheroscler. Rep 3, 47-53.
29. Teede HJ, Dalais FS, Kotsopoulos D, Liang YL, Davis S & McGrath BP (2001): Dietary soy has both beneficial and potentially adverse cardiovascular effects: a placebo-controlled study in men and postmenopausal women. J. Clin. Endocrinol. Metab. 86, 3053-3060.
30. Teixeira SR, Potter SM, Weigel R, Hannum S, Erdman JW & Hasler CM (2000): Effects of feeding 4 levels of soy protein for 3 and 6 wk on blood lipids and apolipoproteins in moderately hypercholesterolemic men. Am. J. Clin. Nutr. 71, 1077-1084.
31. Van Horn L, Liu K, Gerber J, Garside D,'Schiffer L, Gernhofer N & Greenland P (2001): Oats and soy in lipid-lowering diets for women with hypercholesterolemia: is there synergy? J. Am. Diet. Assoc 101, 1319-1325.
32. Vigna GB Pansini F Bonaccorsi G Albertazzi P Donega P Zanotti L De Aloysio D Mollica G & Fellin R (2000): Plasma lipoproteins in soy-treated postmenopausal women: a double-blind, placebo-controlled trial. Nutr. Metab. Cardiovasc. Dis. 10, 315-322.
33. Vitolins MZ Anthony M & Burke GL (2001): Soy protein isoflavones, lipids and arterial disease. Curr. Opin. Lipidol. 12, 433-437.
34. Weggemans RM Zock PL & Katan MB (2001): Dietary cholesterol from eggs increases the ratio of total cholesterol to high-density lipoprotein cholesterol in man. A meta-analysis. Am. J. Clin. Nutr. 73, 885-891.